Current location - Education and Training Encyclopedia - Graduation thesis - Therapeutic effect of mycelium extract AHCC (Enoch) on patients with COVID-19's disease.
Therapeutic effect of mycelium extract AHCC (Enoch) on patients with COVID-19's disease.
In March 2020, coronavirus pneumonia -20 19, the epidemic situation in COVID-19 accelerated, and the epidemic situation in China was about to dawn, but the epidemic situation abroad was rapidly deteriorating, showing a global epidemic trend. Faced with this unprecedented challenge, Professor Piero of Velleja Institute in Italy published a scientific research paper (Minerva Gastroenterologia Edietologica 2018-19 Impact Factor 2.360) in the journal Gastroenterology and Nutrition on March/2, which attracted wide attention.

At present, novel coronavirus -20 19 has involved more than 120 countries, with more than 12000 deaths, and nearly 6,000 deaths in Italy alone. According to the World Health Organization (WHO), worldwide, the epidemic situation in COVID-19 is still in the initial stage of epidemic development, and most countries have not yet seen widespread community transmission. The global epidemic is still in the process of accelerating its spread, and it is still too early to get rid of it. The virus has high concealment, it is difficult to find all of it, and the basic infection rate of R0 is high. At present, there is no specific medicine or vaccine. To make the virus disappear, we can only rely on our own immune ability.

At present, in the study of human immunity, AHCC (Enoch) has detailed and rigorous evidence-based medical evidence, which has attracted great attention all over the world. It is an advanced basidiomycete extract based on acetylated α-glucan. It has been proved to be effective in the study of immune reagents and protective immune responses of animals and humans affected by West Nile virus, influenza virus, avian influenza virus (H5N 1), human virus (human papillomavirus), hepatitis C virus, herpes virus, hepatitis B virus and HIV. These studies show that AHCC activates or increases the key cells of the early defense system of the immune system, such as NK (natural killer) cells, NKT (natural killer T) cells and γδT(γδT) cells, so the effectiveness of Enoch in infectious diseases is considered to be mainly attributed to the activation of the innate immune system. In addition, there are many research reports on the immunomodulatory effect of enoxacin in areas other than infection.

At present, there is no effective intervention method for COVID-19 in novel coronavirus. Although the curative effect of AHCC on COVID-19's disease has not been specifically evaluated, its role in promoting human immune activation against various virus infections can support its application in the prevention and treatment of diseases caused by pathogenic coronavirus, including coronavirus pneumonia -20 19 COVID-19.